In part II of his conversation with Dr Nick Lynch, founder of Curlew Research, Raminderpal Singh asks the uncomfortable ...
A novel epigenetic therapy has demonstrated activity against treatment-resistant acute myeloid leukaemia in preclinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results